Biktarvy and Sulfamethoxazole Do Not Cause Acute Sinusitis or Congestive Symptoms
Neither Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) nor trimethoprim-sulfamethoxazole cause acute sinusitis or congestive symptoms—in fact, trimethoprim-sulfamethoxazole is a treatment for acute bacterial rhinosinusitis, not a cause of it.
Understanding the Medications and Their Relationship to Sinusitis
Biktarvy's Safety Profile
According to the FDA drug label, the most common adverse reactions (≥5%) reported with Biktarvy are diarrhea, nausea, and headache 1. Respiratory symptoms, including sinusitis or nasal congestion, are not listed among the adverse reactions in clinical trials involving over 1,000 patients through 144 weeks 1.
The documented adverse effects include:
- Gastrointestinal: diarrhea (3-6%), nausea (3-6%), abdominal distention (1-2%)
- Neurological: headache (4-5%), dizziness (1-2%), insomnia (2%)
- General: fatigue (2-3%), abnormal dreams (1-3%)
Recent real-world pharmacovigilance data from FAERS identified unexpected signals including pancreatitis, dysphagia, and mental disorders, but respiratory or sinus symptoms were not among the identified adverse events 2. A 24-month real-world study in Japan showed high tolerability with diarrhea and weight gain as the most common drug-related adverse events, with no mention of sinusitis 3.
Trimethoprim-Sulfamethoxazole: A Treatment, Not a Cause
Trimethoprim-sulfamethoxazole (TMP-SMX) is specifically used to treat acute bacterial rhinosinusitis, not cause it. Multiple guidelines from 1992-2004 list TMP-SMX as an acceptable antibiotic option for acute sinusitis 4, 5.
In penicillin-allergic patients with mild disease, TMP-SMX is recommended as a first-line alternative 6, 7. Research demonstrates that TMP-SMX (Bactrim) actually reduces inflammatory response in bacterial sinusitis by decreasing neutrophil infiltration and bacterial growth 8.
The FDA label for TMP-SMX lists overdose symptoms as anorexia, nausea, vomiting, dizziness, headache, and potential blood dyscrasias—but not sinusitis or nasal congestion 9.
What Actually Causes Acute Sinusitis
Acute bacterial rhinosinusitis is caused by:
- Bacterial pathogens: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 4, 10, 5
- Viral upper respiratory infections that precede bacterial superinfection 4, 11
- Allergic rhinitis, GERD, or anatomic obstruction 10
Clinical criteria for bacterial sinusitis requiring antibiotics include 11:
- Persistent symptoms >10 days without improvement
- Severe symptoms: fever >39°C with purulent nasal discharge or facial pain for ≥3 consecutive days
- "Double sickening": worsening after initial improvement at 5-7 days
Clinical Pitfalls to Avoid
Do not confuse viral rhinosinusitis with bacterial sinusitis. Most acute rhinosinusitis cases are viral and self-limited, with congestive symptoms being part of the viral illness itself, not a medication side effect 11, 6. The guidelines emphasize that diffuse, bilateral nasal symptoms with moderate congestion in an epidemic context do not require antibiotics 12.
Do not attribute common cold symptoms to medications. If a patient on Biktarvy or TMP-SMX develops nasal congestion and sinus pressure, consider:
- Concurrent viral upper respiratory infection (most common)
- Allergic rhinitis
- Underlying immunodeficiency (relevant in HIV patients on Biktarvy) leading to increased infection susceptibility 10
Important consideration for HIV patients on Biktarvy: Immune reconstitution inflammatory syndrome (IRIS) is a documented adverse effect (ROR 76.26) 1, which could theoretically manifest with inflammatory symptoms, but this is distinct from infectious sinusitis.
Bottom Line
If your patient on Biktarvy and/or TMP-SMX develops acute sinusitis with congestive symptoms, look for the actual cause—a concurrent viral or bacterial infection, not the medications themselves. TMP-SMX is treating sinusitis, not causing it, and Biktarvy has no established association with respiratory or sinus symptoms in extensive clinical trial and post-marketing data.